Comparative study of BBB-crossing AAV capsids for central nervous system delivery efficiency

Related articles

1. Comparative analysis of microglia-targeted AAVs reveals capsid choice drives efficiency in vitro but has limited impact in vivo

   This article has 25 authors:

   1. Saša Jereb
   2. Lia R. D’Alessandro
   3. Nader Morshed
   4. Margery Chen
   5. Rafaela Sartore
   6. Zengpeng Han
   7. Jordan E. McKinney
   8. Pamela P. Brauer
   9. John W. Harvey
   10. Matthew Demers
   11. Dara Cuffe
   12. Raphael Rakosi-Schmidt
   13. Luira Leite
   14. Youtong Huang
   15. Qingxia Zheng
   16. Chin-Yen Lin
   17. Ken Y. Chan
   18. Bryan J. Song
   19. Michael R. Farzan
   20. Paola Arlotta
   21. Morgan Sheng
   22. Mariko L. Bennett
   23. Matthew B. Johnson
   24. Beth Stevens
   25. Benjamin E. Deverman

2. pH-dependent anti-TfR1 NANOBODY® molecules deliver efficacious oligonucleotide payloads to muscle and CNS tissues

   This article has 20 authors:

   1. EA Hoyt
   2. K Moonens
   3. C Rapisarda
   4. AM Salvador
   5. TR Hammond
   6. S Kharade
   7. R Mondragon-Gonzalez
   8. F Moran
   9. S Ramkumar
   10. J Thummapudi
   11. S Zhou
   12. G Haussy
   13. C Capdevila
   14. F Maillard
   15. A Ismail
   16. L Avery
   17. P Sardi
   18. C Nonne
   19. S Cornelis
   20. N Leksa

3. Lipid–ASO therapeutics exhibit differential tissue targeted delivery upon systemic or local CNS administration

   This article has 17 authors:

   1. Samantha Roudi
   2. H. Yesid Estupiñán
   3. Osama Saher
   4. Cristiana Barradas
   5. Emma Inganäs
   6. Hoang-Ngoan Le
   7. Nicolai Frengen
   8. Radoslaw Grochowski
   9. Svetlana Pavlova
   10. Robert Månsson Welinder
   11. Joel Z. Nordin
   12. Annabelle Biscans
   13. Pär Matsson
   14. Rula Zain
   15. Rickard Sandberg
   16. Michael Hagemann-Jensen
   17. Samir El Andaloussi